ProfileGDS5678 / 1429720_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 81% 80% 80% 79% 80% 83% 82% 80% 80% 80% 82% 80% 80% 80% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 15.7395281
GSM967853U87-EV human glioblastoma xenograft - Control 25.689480
GSM967854U87-EV human glioblastoma xenograft - Control 35.6960780
GSM967855U87-EV human glioblastoma xenograft - Control 45.6417679
GSM967856U87-EV human glioblastoma xenograft - Control 55.6635680
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 15.8116483
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 25.7316882
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 35.6772980
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 45.632580
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 15.7197380
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 25.8647282
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 35.6411580
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 45.6599480
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 55.6814880